Chicago White Sox re-sign Pitcher Mike Clevinger for 2024 Season
The Chicago White Sox have inked a new deal with pitcher Mike Clevinger for the 2024 season, showcasing a continued commitment to bolstering their pitching roster. This contract arranges for Clevinger to earn $3 million over the course of the season, with the potential to double that amount, reaching up to $6 million through performance incentives. This agreement is presently awaiting completion, contingent upon Clevinger passing a physical examination—a standard procedure in such negotiations.
### Reflecting on Clevinger's Journey
Clevinger's path to this current contract began last winter when he signed a one-year deal with the White Sox valued at $12 million. That period in his career was shadowed by investigations into allegations surrounding domestic violence. It's important to note that these investigations did not culminate in formal disciplinary action against him.
On the mound, Clevinger delivered a commendable performance throughout the season. Over 131 1/3 innings pitched, he maintained a 3.77 ERA. Despite facing challenges, including two stints on the injured list, he showcased resilience. Notably, Clevinger underwent Tommy John surgery in November 2020—a significant procedure for any pitcher, potentially affecting performance.
Analyzing his last season's performance, Clevinger had a 20% strikeout rate, which, while respectable, fell below the league average for pitchers. Some of his success can be attributed to a .281 batting average on balls in play (BABIP) and a 77.2% strand rate, suggesting he benefited from favorable outcomes. However, advanced metrics like a 4.28 Fielding Independent Pitching (FIP) and a 4.81 Skill-Interactive ERA (SIERA) hinted at underlying struggles, indicating that his ERA might have painted a rosier picture than warranted.
### The Outlook for 2024
As the White Sox prepare for the 2024 season, changes to their pitching lineup are anticipated, with Clevinger expected to play a significant role in their rotation. Given his recent surgery and the need to regain peak fitness and performance levels, there is acknowledgement within the organization that Clevinger might require some time to return to his best form. This situation opens the door to potential adjustments within the team's starting rotation, including the possibility of trades involving current starters.
Clevinger's focus is on refining his pitching techniques and mechanics to boost his strikeout rate and overall effectiveness on the mound. By re-signing Clevinger, the White Sox are demonstrating confidence in his ability to overcome recent challenges and contribute significantly to their pitching staff's success.
In summary, the White Sox's decision to re-sign Mike Clevinger on a deal that is both performance-driven and reflective of his potential to bounce back is a calculated risk. It acknowledges his previous contributions, the hurdles he's faced, and the underlying belief in his capacity for improvement. As the team navigates the offseason and looks towards 2024, how Clevinger responds to this opportunity could play a pivotal role in shaping the White Sox's fortunes on the field.
